-
Product Name
Nimacimab reference antibody
- Documents
-
Description
Anti-CB1 / CNR1 Antibody (Nimacimab)
-
Tested applications
ELISA
-
Species reactivity
Human CB1 / CNR1
-
Isotype
IgG4
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
50mM Pro-Ac pH5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
Bioactivity: FACS
Human CB1 / CNR1 EGFP HEK293 Cell Line were stained with Anti-CB1 / CNR1 Antibody (nimacimab) and negative control protein respectively, washed and then followed by APC and analyzed with FACS, EC50=0.028 ug/mL.
SDS-PAGE
Anti-CB1 / CNR1 Antibody (nimacimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-CB1 / CNR1 Antibody (nimacimab) is 99.42%, determined by SEC-HPLC.
ELISA
Immobilized Human CB1 VLP at 5 ug/mL (30 uL/well) can bind Monoclonal Anti-CB1 / CNR1 Antibody (nimacimab), The EC50 was approximately 0.04092 µg/ml.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"